Barclays »

Alpine Immune Sciences shares owned by Barclays

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5M 80k 19.07
2023-09-30 $104k 9.1k 11.40
2023-06-30 $65k 6.3k 10.28
2023-03-31 $93k 12k 7.70
2022-12-31 $45k 6.1k 7.40
2022-09-30 $5.0k 662 7.55
2022-06-30 $7.0k 783 8.94
2022-03-31 $17k 1.9k 9.01
2021-12-31 $196k 14k 13.90
2021-09-30 $51k 4.7k 10.74
2021-06-30 $13k 1.5k 8.85
2021-03-31 $150k 14k 10.63
2020-09-30 $25k 2.8k 8.95
2019-09-30 $0 2 0.00
2018-03-31 $999 134 7.46